The purpose of this paper was to determine the effects of blood type, delayed centrifugation, type of plasma filtration system and frozen storage of plasma on coagulation parameters.
The bioequivalence of frozen plasma prepared from whole blood held overnight at room temperature compared to fresh-frozen plasma prepared within eight hours of collection.
Dumont LJ, Cancelas JA, Maes LA, Rugg N, Whitley P, Herschel L, Siegel AH, Szczepiorkowski ZM, Hess JR, Zia M
Purpose
Conclusion
Filtration with LEUKOSEP HWB-600-XL caused significant changes in prothrombin time (PT) and activated partial thromboplastin time (aPTT) compared to when plasma was unfiltered, regardless of time before centrifugation. The red blood cell (RBC) filtration system (LEUKOSEP HWB-600-XL versus the RZ2000 system) affected levels of TAT, fibrinopeptide A (FPA) and complement fragment C5a. Storage of blood for 24 h before centrifugation resulted in significant differences in Factor (F)VIII activity and thrombin–antithrombin complex (TAT) compared to blood centrifuged within 8 h, regardless of whether or not the blood was filtered. Frozen storage of plasma significantly affected FPA, FVIII, antithrombin and fragment 1+2 (F1+2) levels, but only FVIII levels in specimens stored for 24 h before centrifugation were outside the bioequivelance (BE) range of 0.8-1.25. While plasma from group O donors had lower von Willebrand Ristocetin Cofactor (VWF-RCo) and FVIII levels than that from other blood groups, the storage duration and processing variables affected all blood groups similarly.
Studies (1)
Purpose
The purpose of this study was to determine the effects of blood type, delayed centrifugation, type of plasma filtration system, and frozen storage of plasma on coagulation parameters. Blood was collected from 180 healthy patients and either held for 6 h before filtration of RBCs with RZ2000 leukoreduction filter into AS-1 and centrifugation (control), held for <8 h (test) or 20-24 h (PF24RT24WB) before filtration of RBCs with LEUKOSEP HWB-600-XL into AS-7 (SOLX) and centrifugation. Test plasma was analyzed at room temperature and then frozen at -18°C and stored at -70°C for 3-12 months while control plasma was frozen before analysis. After storage, specimens were shipped on dry ice to a central laboratory for thawing and analysis.
Summary of Findings
Filtration with LEUKOSEP HWB-600-XL increased PT in plasma from blood stored at room temperature <8h (p=0.0193) or 20-24 h (PF24RT24WB) (p<0.0001) and increased aPTT in PF24RT24WB (p<0.0001) compared to when no filtration was performed. Increased storage of whole blood reduced FVIII activity and TAT as FVIII activity was lower in PF24RT24WB than test plasma when filtered (p=0.035) or not filtered (p=0.019) and TAT was lower in PF24RT24WB that in test plasma (p<0.05). Filtration with LEUKOSEP HWB-600-XL (test and PF24RT24WB) as opposed to RZ2000 (contol) resulted in lower TAT, FPA and complement fragment C5a levels (p<0.05, all). Frozen storage significantly increased antithrombin and decreased FPA. In the first 6 months, F1+2 was also decreased, but after 12 months, levels were comparable to (test or PF24RT24WB) or higher than (control) initial levels. After frozen storage of plasma, all coagulation factors in plasma from blood stored <8 h (test and control) fell within the BE range of 0.8-1.25 of the control prior to storage. However, PF24RT24WB had a lower confidence level (LCL) for FVIII which resulted in a longer aPTT. Further, while remaining within the BE guidelines, PF24RT24WB had lower protein S and higher FX and FVII levels after frozen storage. While plasma from group O donors had lower VWF-RCo and FVIII levels than that from other blood groups, the storage duration and processing variables investigated did not differentially affect blood groups.
Biospecimens
FluidBloodFluidPlasmaPreservation Types
FrozenNone (Fresh)Diagnoses
NormalPlatforms
MorphologyHematology/ auto analyzerProteinELISAProteinHematology/ auto analyzerProteinImmunoturbidometric assayProteinSpectrophotometryCell count/volumeHematology/ auto analyzerPeptideELISAPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Patient genotype Type A bloodType AB bloodType B bloodType O bloodBiospecimen Aliquots and Components Blood processing method LEUKOSEP HWB-600-XL leukoreduction filterRZ2000 leukoreduction filterBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedBiospecimen Aliquots and Components Filtration LEUKOSEP HWB-600-XL filteredRZ2000 filteredUnfilteredStorage Storage duration 12 months20-24 h3 months6 months<8 hStorage Time at room temperature 20-24 h<8 h